Selective oestrogen therapy for perimenopausal or postmenopausal

Details Selective oestrogen therapy for perimenopausal or postmenopausal Selective oestrogen therapy for perimenopausal or postmenopausal

1989-06-06

1993-02-02

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514170, 514182, 514622, 514708, 514709, 514710, 514712, 514713, A61K 3156, A61K 31165, A61K 3110

Patent

active

051838141

ABSTRACT:
The invention relates to a therapeutic product comprising an oestrogen and a pure antioestrogen for simultaneous, sequential or separate use in selective oestrogen therapy of perimenopausal or postmenopausal conditions; to a process for the manufacture of said product and to a pharmaceutical composition containing said product. The invention also relates to a pharmaceutical composition comprising an oestrogen and a pure antioestrogen and to a process for the manufacture of said composition.

REFERENCES:
patent: 4659516 (1987-04-01), Bowler et al.
patent: 4732912 (1988-03-01), Pilgrim et al.
patent: 4826831 (1989-05-01), Plunkett et al.
patent: 4894373 (1990-01-01), Young
Volker et al, Maturitas, 10:157-159 (1988).
Ottosson et al, Gynecol. obstet. Invest., 18:140-146; 296-302 (1984).
Chemical Abstracts, vol. 109, No. 3, Jul. 18, 1988, p. 73, Abstract No. 17199p.

Affiliated with

Also associated with

Rating

Selective oestrogen therapy for perimenopausal or postmenopausal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selective oestrogen therapy for perimenopausal or postmenopausal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective oestrogen therapy for perimenopausal or postmenopausal will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-7002